REGN

REGN

Regeneron Pharmaceuticals Inc
Biotechnology
$805.02 -1.72% As of Oct 23, 9:02 PM
Loading chart...
Interactive chart powered by TradingView

Trade Idea

Strategy
Bull Call
Strikes
$815/820
Expiration
Oct 16
Target ROI
100.0%
Trade Reasoning
The current stock price of $818.16 is positioned just below the $820 strike, indicating a strong likelihood of upward momentum. With no identified technical risk factors, this is an optimal entry point for a Bull Call Spread, allowing us to capitalize on anticipated price movement. The ATM spread structure enhances our risk/reward profile by limiting downside exposure while maximizing profit potential as the stock moves towards and above the $820 strike. Maya's edge comes from disciplined trade management—knowing when to exit is just as important as when to enter. Subscribe to get real-time open and close alerts that take the guesswork out of trading.

Technical Analysis

REGN Holds Bullish Structure Above $805.02

Bullish
Oct 23, 2026 at 9:02 PM • $805.02 (-1.72%)

Shares of Regeneron Pharmaceuticals Inc (REGN) declined 1.72% to $805.02 on October 23.

The technical picture is bullish:

Momentum RSI at 58.1 is neutral but improving. MACD reads 8.15 against its 0.82 signal line (bullish).
Moving Averages Moving averages are stacked bullishly—9-day EMA ($794.11) supports, 21-day ($782.32) below.
Volatility Bollinger Band width at 14.8% indicates normal volatility.

Traders are watching $709.48 on the downside and $823.03 on the upside.

REGN Clears Resistance, EMAs Confirm at $819.09

Bullish
Oct 22, 2026 at 9:02 PM • $819.09 (+1.67%)

REGN Bounces Off EMAs, Climbs to $805.67

Bullish
Oct 21, 2026 at 9:02 PM • $805.67 (-0.23%)

Moving Averages Propel REGN to $807.48

Bullish
Oct 20, 2026 at 9:02 PM • $807.48 (+3.26%)

REGN Bounces Off EMAs, Climbs to $782.04

Bullish
Oct 19, 2026 at 9:02 PM • $782.04 (-1.10%)
Systematic technical analysis • Updated daily after market close

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Subscribe Now Try Scanner

Key Stats

Entry Price $2.50
Max Profit $2.50
Max Loss $2.50
Days to Exp -7
Trade Date Sep 8, 2026

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
BIIB
BIIB
Biogen Inc
MRNA
MRNA
Moderna Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.